# A Study to Assess Safety and Efficacy of a Novel Patch Infusor Device and Novel SUBCUTaneous Furosemide Formulation Combination in Patients With Heart Failure

> **NCT04846816** · PHASE1 · COMPLETED · sponsor: **SQ Innovation, Inc.** · enrollment: 20 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **COMBINATION_PRODUCT:** SQIN-01

## Key facts

- **NCT ID:** NCT04846816
- **Lead sponsor:** SQ Innovation, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-06
- **Primary completion:** 2021-08-13
- **Final completion:** 2021-08-13
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04846816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04846816, "A Study to Assess Safety and Efficacy of a Novel Patch Infusor Device and Novel SUBCUTaneous Furosemide Formulation Combination in Patients With Heart Failure". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04846816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*